{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:55:55Z","timestamp":1794610555344,"version":"4.9.1"},"reference-count":22,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Histiocytoses are rare disorders of unknown origin with highly heterogeneous prognosis. BRAF mutations have been observed in Langerhans cell histiocytosis (LCH). We investigated the frequency of BRAF mutations in several types of histiocytoses. Histology from 127 patients with histiocytoses were reviewed. Detection of BRAFV600 mutations was performed by pyrosequencing of DNA extracted from paraffin embedded samples. Diagnoses of Erdheim-Chester disease (ECD), LCH, Rosai-Dorfman disease, juvenile xanthogranuloma, histiocytic sarcoma, xanthoma disseminatum, interdigitating dendritic cell sarcoma, and necrobiotic xanthogranuloma were performed in 46, 39, 23, 12, 3, 2, 1, and 1 patients, respectively. BRAF status was obtained in 93 cases. BRAFV600E mutations were detected in 13 of 24 (54%) ECD, 11 of 29 (38%) LCH, and none of the other histiocytoses. Four patients with ECD died of disease. The high frequency of BRAFV600E in LCH and ECD suggests a common origin of these diseases. Treatment with vemurafenib should be investigated in patients with malignant BRAFV600E histiocytosis.<\/jats:p>","DOI":"10.1182\/blood-2012-05-430140","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:59:10Z","timestamp":1344560350000},"page":"2700-2703","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":633,"title":["High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses"],"prefix":"10.1182","volume":"120","author":[{"given":"Julien","family":"Haroche","sequence":"first","affiliation":[{"name":"Department of Internal Medicine & French Reference Center for Rare Auto-immune & Systemic Diseases, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris 06, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Charlotte","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France and University Paris 6, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine & French Reference Center for Rare Auto-immune & Systemic Diseases, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris 06, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"H\u00e9lias-Rodzewicz","sequence":"additional","affiliation":[{"name":"EA4340, Versailles University, Boulogne, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Hervier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine & French Reference Center for Rare Auto-immune & Systemic Diseases, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris 06, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Cohen-Aubart","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine & French Reference Center for Rare Auto-immune & Systemic Diseases, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris 06, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Claude-Huriez, Centre Hospitalier Regional Universitaire Lille, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Lesot","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France and University Paris 6, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Mokhtari","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Raymond Escourolle, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France and University Paris 6, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Canioni","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Necker-Enfants Malades, Paris, France and University Paris 5, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Galmiche","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Necker-Enfants Malades, Paris, France and University Paris 5, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Onco-hematology, H\u00f4pital Saint Vincent de Paul, UC de Lille, Universit\u00e9 Nord de France, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of T\u00fcbingen, T\u00fcbingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Croockewit","sequence":"additional","affiliation":[{"name":"Department of Hematology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Kambouchner","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Avicenne, AP-HP, Universit\u00e9 Paris 13, Bobigny, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Copin","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Fraitag","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Necker-Enfants Malades, Paris, France and University Paris 5, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brousse","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Necker-Enfants Malades, Paris, France and University Paris 5, AP-HP, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine & French Reference Center for Rare Auto-immune & Systemic Diseases, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France;"},{"name":"Universit\u00e9 Pierre et Marie Curie, Universit\u00e9 Paris 06, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Donadieu","sequence":"additional","affiliation":[{"name":"Department of Pediatry, AP-HP, Centre de R\u00e9f\u00e9rence des histiocytoses, H\u00f4pital Trousseau, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Emile","sequence":"additional","affiliation":[{"name":"EA4340, Versailles University, Boulogne, France;"},{"name":"Department of Pathology, H\u00f4pital Ambroise Par\u00e9, AP-HP, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"I","key":"2019111809425445100_B1","first-page":"208","article-title":"Histiocytosis syndromes in children.","volume":"329","author":"Writing Group of the Histiocyte Society","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"2019111809425445100_B2","first-page":"365","article-title":"Histiocytosis X histogenetic arguments for a Langerhans cell origin.","volume":"18","author":"Nezelof","year":"1973","journal-title":"Biomedicine"},{"issue":"6","key":"2019111809425445100_B3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00000478-199506000-00003","article-title":"Langerhans' cell histiocytosis: definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples.","volume":"19","author":"Emile","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"2019111809425445100_B4","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Skin","author":"LeBoit","year":"2006"},{"key":"2019111809425445100_B5","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"27","key":"2019111809425445100_B6","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1200\/JCO.2005.08.036","article-title":"Raf: a strategic target for therapeutic development against cancer.","volume":"23","author":"Beeram","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6892","key":"2019111809425445100_B7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer.","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"26","key":"2019111809425445100_B8","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation.","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111809425445100_B9","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis.","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111809425445100_B10","doi-asserted-by":"crossref","first-page":"e33891","DOI":"10.1371\/journal.pone.0033891","article-title":"B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease.","volume":"7","author":"Satoh","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2019111809425445100_B11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.21498","article-title":"Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.","volume":"51","author":"Guyot-Goubin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2019111809425445100_B12","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","article-title":"CNS involvement and treatment with interferon-\u03b1 are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients.","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"key":"2019111809425445100_B13","article-title":"Prognostic value of BRAF (V600) mutations in melanoma patients after resection of metastatic lymph nodes [published online ahead of print July 7, 2012].","author":"Moreau","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2019111809425445100_B14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","article-title":"Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.","volume":"122","author":"Capper","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2019111809425445100_B15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199407213310303","article-title":"Langerhans'-cell histiocytosis (histiocytosis X): a clonal proliferative disease.","volume":"331","author":"Willman","year":"1994","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111809425445100_B16","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2010-10-313510","article-title":"Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients.","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111809425445100_B17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0046-8177(99)90228-9","article-title":"Chester-Erdheim disease: a neoplastic disorder.","volume":"30","author":"Chetritt","year":"1999","journal-title":"Hum Pathol"},{"issue":"2","key":"2019111809425445100_B18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.pas.0000213366.33627.a0","article-title":"Clonal cytogenetic abnormalities in Erdheim-Chester disease.","volume":"31","author":"Vencio","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2019111809425445100_B19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.annder.2011.06.002","article-title":"Associated Langerhans cell histiocytosis and Erdheim-Chester disease.","volume":"138","author":"Marchal","year":"2011","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"2019111809425445100_B20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/adc.75.1.17","article-title":"A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993.","volume":"75","author":"French Langerhans' Cell Histiocytosis Study Group","year":"1996","journal-title":"Arch Dis Child"},{"issue":"10","key":"2019111809425445100_B21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1056\/NEJM200409023511022","article-title":"Imatinib mesylate for cerebral Langerhans'-cell histiocytosis.","volume":"351","author":"Montella","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111809425445100_B22","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1182\/blood-2008-03-148304","article-title":"Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis.","volume":"111","author":"Haroche","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/13\/2700\/1358272\/zh803912002700.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/13\/2700\/1358272\/zh803912002700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T10:37:22Z","timestamp":1574073442000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/13\/2700\/30812\/High-prevalence-of-BRAF-V600E-mutations-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,27]]},"references-count":22,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,9,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-05-430140","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,27]]}}}